Skip to Main Content

Richard A. Morgan. Ex vivo applications of Cas12a. Presented at the Keystone Symposia: Engineering the Genome, February 8-12, 2020.

February 12, 2020

Editas Newsroom

Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference

Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering

Editas Medicine Announces Proposed Public Offering